MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Hallucinations"

  • 2022 International Congress

    Visual Hallucinations and Parkinson’s Disease Neuropathology among Decedents with and without Parkinson’s Disease or Lewy Body Dementia During Life

    H. Petrovitch, R. Abbott, M. Barrett, K. Masaki, C. Tanner, J. Uyehara-Lock, W. Ross (Honolulu, USA)

    Objective: The purpose of this report is to examine the association between visual hallucinations during life and substantia nigra (SN) neuron density and Lewy pathology…
  • 2022 International Congress

    TWO-YEAR LONGITUDINAL FOLLOW-UP OF VISUAL ILLUSIONS AND HALLUCINATIONS IN PARKINSON’S DISEASE

    S. Beze, L. Castellani, B. Pereira, F. Chiambaretta, F. Durif, A. Marques (Clermont-Ferrand, France)

    Objective: To determine whether visual illusions (VI) evolve towards visual hallucinations (VH) along the time in Parkinson’s disease (PD), and whether ophthalmological treatment may have…
  • 2022 International Congress

    Phantom boarder syndrome associated with experimentally-induced presence hallucinations in Parkinson’s disease

    J. Potheegadoo, F. Bernasconi, O. Blanke (Geneva, Switzerland)

    Objective: Measuring experimentally-induced presence hallucinations in patients with Parkinson’s disease phantom boarder phenomena. Background: Phantom boarder syndrome (PB) is described as the sensation that someone…
  • MDS Virtual Congress 2021

    Parkinson’s-disease risk variants are differentially associated with discrete phenotypic characteristics of Parkinson’s-disease at baseline.

    B. Chase, A. Premkumar, B. Schoneburg, N. Kartha, J. Wei, H. Yu, A. Epshteyn, L. Garduno, A. Pham, R. Vazquez, R. Frigerio, D. Maraganore, K. Markopoulou (Skokie, USA)

    Objective: Evaluate whether genetic risk variants for Parkinson’s disease discovered in case-control GWAS uniformly or differentially contribute to the clinical phenotype of PD. Background: Genetic…
  • MDS Virtual Congress 2021

    Clinical correlates of visual hallucinations in Parkinson’s disease

    G. Mandic Stojmenovic, T. Stojkovic, E. Stefanova, V. Markovic, I. Stankovic Tutus, I. Petrovic, N. Dragasevic Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)

    Objective: The aim of this study is to identify frequency and clinical (motor and nonmotor) correlates of VH predictors of their development after a follow-up…
  • MDS Virtual Congress 2021

    Parkinson’s disease patients with hallucinations exhibit dopaminergic degeneration and cortical thinning

    C. Wertz, K. Poston, N. Shaff, A. Hartman, A. Horner, A. Mayer, A. Vakhtin, A. Deligtisch, S. Pirio Richardson, S. Ryman (Albuquerque, USA)

    Objective: Examine whether Parkinson’s disease patients (PD) who experience hallucinations (PD+hall) exhibit a greater decline in striatal dopamine and corresponding posterior cortical decline relative to…
  • MDS Virtual Congress 2020

    Genetic risk scores and hallucinations in Parkinson’s disease patients

    C. Kusters, K. Paul, A. Duarte Folle, A. Keener, J. Bronstein, V. Dobricic, O.B Tysnes, L. Bertram, G. Alves, J. Sinsheimer, C. Lill, J. Maple-Grødem, B. Ritz (Los Angeles, CA, USA)

    Objective: To examine the overlap of genetic architecture for Alzheimer’s disease (AD), schizophrenia (SZ), and PD with the genetic architecture for the occurrence of hallucinations…
  • MDS Virtual Congress 2020

    Management of neuropsychiatric symptoms in Parkinson’s disease (PD) at the front door

    M.A Farooqi, A. Chatterjee (Reading, United Kingdom)

    Objective: To ascertain the number of PD patients admitted to the acute hospital with neuropsychiatric symptoms requiring a review by PD specialist, including medicine reconciliation…
  • MDS Virtual Congress 2020

    Non-motor Symptoms in Advanced- vs Non-advanced Parkinson’s Disease: A Subgroup Analysis of the OBSERVE-PD Observational Study

    A. Fasano, L. Bergmann, V. SC Fung, K. Onuk, K. Seppi, Z. Pirtosek (Toronto, ON, Canada)

    Objective: To report intercountry differences in non-motor symptoms in patients with advanced Parkinson’s Disease (APD) vs non-APD. Background: There is no standard criteria for the…
  • MDS Virtual Congress 2020

    Visual Hallucinations and Illusions in Parkinson’s Disease: The Role of Ocular Pathology

    A. Marques, S. Beze, B. Pereira, C. Chassain, N. Monneyron, L. Delaby, C. Lambert, P. Derost, B. Debilly, I. Rieu, S.G Lewis, F. Chiambaretta, F. Durif (Clermont-Ferrand, France)

    Objective: To determine whether different mechanisms could lead to the emergence of visual hallucinations (VH) (defined as false perceptions with no external stimulus) versus illusions…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 11
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley